通过使用最小的PBPK建模和目标实现分析来确定肺炎患者适合的斯福米辛 (ZTI-01) 剂量方案
Jomana Al Hroot1, Joshua Reeder1, Xuanzhen Yuan1
1Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, USA.
Antimicrobial agents and chemotherapy
|May 5, 2025
概括
斯福米辛在肺炎治疗中显示出有前途的效果. 一个新的药物动力学模型预测了感染部位的较低药物水平,这表明可能需要更高的剂量来有效治疗抗药性细菌,如Pseudomonas aeruginosa.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 计算生物学 计算生物学
背景情况:
- 斯福米是一种广泛的抗生素,有效治疗无并发性囊炎.
- 抗生素耐药性需要探索肺炎的新疗法.
- 斯福米对抗耐药性肺炎的潜力需要进一步调查.
研究的目的:
- 开发一个最小的生理学基础的药理动力学 (m-PBPK) 模型,用于氏菌素.
- 预测肺炎患者感染部位的斯福米辛度.
- 评估治疗医院获得的肺炎的最佳剂量方案.
主要方法:
- 从血,上皮层层液 (ELF) 和膜巨细胞 (AMs) 收集的药理动力学数据.
- 开发了一种机械的m-PBPK模型,将肺炎的病理生理变化纳入其中.
- 使用蒙特卡洛模拟来确定各种剂量实现目标 (PTA) 的概率.
主要成果:
- m-PBPK模型预测了肺炎患者感染部位的药物度降低.
- 尽管感染,但血度保持不变.
- 剂量建议有所不同:S. aureus/P.的4g每8小时. 黄金菌 (以ELF为基础),P. aeruginosa (以ELF为基础) 的6g q8h,严重病例的8g q8h.
结论:
- 开发的m-PBPK模型为肺炎的氏胺剂量提供了关键的见解.
- 该模型可以指导临床研究设计并评估其他抗生素的肺内药理动力学.
- 与囊炎相比,有效治疗肺炎可能需要更高的氏素剂量.
更多相关视频
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
6.8K
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
793
相关概念视频
Pneumonia IV: Management
263
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
263
Pulmonary Tuberculosis V
145
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
145
Pneumonia V: Nursing management and Prevention
1.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.6K
Pneumonia III: Complications and Assessment
116
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
116
